iPANDA (image) InSilico Medicine, Inc. Share Print E-Mail Caption Insilico Medicine published a novel tool for deriving new insights from gene expression repositories: in silico Pathway Activation Network Decomposition Analysis (iPANDA). The proof of concept was demonstrated the application of iPANDA as a biomarker developmental tool that can be used in personalized medicine applications. Credit Insilico Medicine Usage Restrictions None Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.